DocGo Inc. DCGO
0.23 USD -0.03 (-10.48%)
At closeNov 10, 2026, 6:40 PM EST
0.24 +0.02 +8.64%
After hours · Nov 10, 6:40 PM ET
0.2149 Day range 0.2774
0.209 52-week range 1.15
- YTD
- -74.33%
- 1 year
- -79.69%
News
benzinga.com Needham Maintains Buy on DocGo, Lowers Price Target to $1 Needham analyst Ryan MacDonald maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $3 to $1.
seekingalpha.com DocGo Inc. (DCGO) Q3 2026 Earnings Call Transcript DocGo Inc. (DCGO) Q3 2026 Earnings Call Transcript
zacks.com DocGo Inc. (DCGO) Reports Q3 Loss, Lags Revenue Estimates DocGo Inc. (DCGO) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.11 per share a year ago.
benzinga.com DocGo Q3 2026 Earnings Call Transcript DocGo (NASDAQ:DCGO) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…- benzinga.com DocGo Board Starts Search For CEO Lee Bienstock's Successor DocGo Inc. (Nasdaq: DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced that the Board has begun a…
benzinga.com DocGo Lowers FY2026 Sales Guidance from $305.000M-$310.000M to $300.000M vs $306.500M Est DocGo (NASDAQ:DCGO) lowers FY2026 sales outlook from $305.000 million-$310.000 million to $300.000 million vs $306.500 million estimate.- benzinga.com DocGo Q3 EPS $(0.17) Misses $(0.09) Estimate, Sales $73.431M Miss $77.194M Estimate DocGo (NASDAQ:DCGO) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.09) by 88.89 percent. This is a 54.55 percent decrease over losses of $(0.11) per…
businesswire.com DocGo Announces Third Quarter 2026 Results and CEO Transition NEW YORK--(BUSINESS WIRE)--DocGo Announces Q3 2026 Results and CEO Transition. Gross Margin Improves 280 Basis Points Over Q2 Due to Company Profitability Initiatives.
businesswire.com DocGo to Announce Third Quarter 2026 Results on Monday, November 9, 2026 NEW YORK--(BUSINESS WIRE)--DocGo to Announce Third Quarter 2026 Results on Monday, November 9, 2026. Management to host conference call and webcast at 5:00 p.m. ET on that day.
defenseworld.net DocGo Inc. (NASDAQ:DCGO) Stock Has Average Target Price of $2.38 DocGo Inc. (NASDAQ: DCGO - Get Free Report) has received an average recommendation of "Hold" from the six ratings firms that are presently covering the stock, Marketbeat reports. One analyst has…
defenseworld.net Lumexa Imaging (NASDAQ:LMRI) versus DocGo (NASDAQ:DCGO) Head-To-Head Comparison Lumexa Imaging (NASDAQ: LMRI - Get Free Report) and DocGo (NASDAQ: DCGO - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses…
defenseworld.net DocGo Eyes Connected Care Platform With Hicuity Health Acquisition DocGo (NASDAQ: DCGO) outlined its planned acquisition of virtual acute-care provider Hicuity Health, describing the transaction as a step toward building a connected care platform spanning…
seekingalpha.com DocGo Inc. (DCGO) Discusses Pending Acquisition of Hicuity Health and Related Financial Projections Transcript DocGo Inc. (DCGO) Discusses Pending Acquisition of Hicuity Health and Related Financial Projections Transcript
defenseworld.net DocGo Inc. (NASDAQ:DCGO) Stock Has Average Price Target of $2.38 Shares of DocGo Inc. (NASDAQ: DCGO - Get Free Report) have received a consensus recommendation of "Hold" from the six brokerages that are currently covering the company, MarketBeat.com reports. One…
gurufocus.com DocGo Announces Upcoming Webinar to Outline Vision and Details of the Pending Hicuity Health Acquisition DocGo Inc. (Nasdaq: DCGO) (âDocGoâ), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bi
businesswire.com DocGo Announces Upcoming Webinar to Outline Vision and Details of the Pending Hicuity Health Acquisition NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bienstock, Chief…
seekingalpha.com DocGo Inc. (DCGO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript DocGo Inc. (DCGO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
gurufocus.com DocGo Announces Upcoming Participation at Morgan Stanley 24th Annual Global Healthcare Conference DocGo Inc. (Nasdaq: DCGO) (âDocGoâ), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bi
businesswire.com DocGo Announces Upcoming Participation at Morgan Stanley 24th Annual Global Healthcare Conference NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bienstock, Chief…
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Alector (NASDAQ:ALEC) shares increased by 9.7% to $2.59 during Tuesday's after-market session. The company's market cap stands at $256.8 million. NeuroSense Therapeutics (NASDAQ:NRSN) shares…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers AIxCrypto Hldgs (NASDAQ:AIXC) stock increased by 132.0% to $1.65 during Tuesday's regular session. The market value of their outstanding shares is at $14.3 million. Amylyx Pharmaceuticals…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Amylyx Pharmaceuticals (NASDAQ:AMLX) stock increased by 27.5% to $27.32 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.3 billion. bioAffinity…
marketbeat.com DocGo Q2 Earnings Call Highlights DocGo NASDAQ: DCGO reported second-quarter revenue of $73.4 million, down from $80.4 million a year earlier, as the company continued to wind down migrant-related projects. Excluding migrant-related…
seekingalpha.com DocGo Inc. (DCGO) Q2 2026 Earnings Call Transcript DocGo Inc. (DCGO) Q2 2026 Earnings Call Transcript
zacks.com DocGo Inc. (DCGO) Surpasses Q2 Earnings Estimates DocGo Inc. (DCGO) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to a loss of $0.11 per share a year ago.- benzinga.com Transcript: DocGo Q2 2026 Earnings Conference Call DocGo (NASDAQ:DCGO) reported second-quarter financial results on Monday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga…
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers INVO Fertility (NASDAQ:IVF) stock moved upwards by 13.1% to $1.73 during Monday's after-market session. The company's market cap stands at $1.7 million. The company's, Q2 earnings came out…
benzinga.com DocGo Narrows FY2026 Sales Guidance from $300.000M-$315.000M to $305.000M-$310.000M vs $306.281M Est DocGo (NASDAQ:DCGO) narrows FY2026 sales outlook from $300.000 million-$315.000 million to $305.000 million-$310.000 million vs $306.281 million estimate.- benzinga.com DocGo Q2 EPS $(0.16) Misses $(0.06) Estimate, Sales $73.425M Miss $75.404M Estimate DocGo (NASDAQ:DCGO) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.06) by 166.67 percent. This is a 45.45 percent decrease over losses of $(0.11)…
businesswire.com DocGo Announces Second Quarter 2026 Results NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial…
benzinga.com DocGo Likely To Report Narrower Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call DocGo Inc. (NASDAQ:DCGO) will release its second earnings report after the closing bell on Monday, Aug. 17.
benzinga.com DocGo Likely To Report Narrower Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call DocGo Inc. (DCGO) to report Q2 earnings on Aug. 17. Expected loss of 15 cents/share. Raised FY sales guidance. Analysts have mixed ratings.- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers BioVie (NASDAQ:BIVI) shares increased by 39.4% to $1.77 during Wednesday's regular session. The market value of their outstanding shares is at $9.5 million. Sionna Therapeutics (NASDAQ:SION)…
businesswire.com DocGo to Announce Second Quarter 2026 Results on Monday, August 17, 2026 NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that the…
benzinga.com DocGo Unit PTI Health Launches Mobile Phlebotomy Services In Southern Florida In conjunction with this launch, PTI Health has expanded its relationship with a major national clinical laboratory to cover services throughout the Southeast and will work collaboratively with this…- benzinga.com DocGo Raises FY2026 Sales Guidance from $290.000M-$310.000M to $300.000M-$315.000M vs $298.871M Est DocGo (NASDAQ:DCGO) raises FY2026 sales outlook from $290.000 million-$310.000 million to $300.000 million-$315.000 million vs $298.871 million estimate.
benzinga.com DocGo Q1 EPS $(0.15) Misses $(0.09) Estimate, Sales $75.550M Beat $72.426M Estimate DocGo (NASDAQ:DCGO) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.09) by 66.67 percent. This is a 66.67 percent decrease over losses of $(0.09) per…
benzinga.com Earnings Scheduled For May 11, 2026 
benzinga.com Canaccord Genuity Maintains Hold on DocGo, Lowers Price Target to $1 Canaccord Genuity analyst Richard Close maintains DocGo (NASDAQ:DCGO) with a Hold and lowers the price target from $1.5 to $1.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session 
benzinga.com Stifel Maintains Buy on DocGo, Lowers Price Target to $2.5 Stifel analyst David Grossman maintains DocGo (NASDAQ:DCGO) with a Buy and lowers the price target from $4 to $2.5.- benzinga.com Cantor Fitzgerald Reiterates Overweight on DocGo, Maintains $3 Price Target Cantor Fitzgerald analyst Sarah James reiterates DocGo (NASDAQ:DCGO) with a Overweight and maintains $3 price target.
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com DocGo Q4 EPS $(1.37) Misses $(0.13) Estimate, Sales $74.936M Beat $70.355M Estimate DocGo (NASDAQ:DCGO) reported quarterly losses of $(1.37) per share which missed the analyst consensus estimate of $(0.13) by 937.88 percent. This is a 3525 percent decrease over earnings of $0.04 per…- benzinga.com Earnings Scheduled For March 16, 2026
- benzinga.com DocGo's Virtual Care Division, SteadyMD, Undertakes Immediate Expansion Of Clinical Workforce, With Plans To Increase Clinical Staff By Up To 50% Over Coming Weeks SteadyMD to Grow Clinical Staff by Up To 50% to Support Customer Base That Includes Multiple Fortune 10 BrandsDocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of…
benzinga.com CORRECTION: DocGo Q3 Adj. EPS $(0.11) Beats $(0.12) Estimate, Sales $70.810M Beat $69.770M Estimate DocGo (NASDAQ:DCGO) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.12) by 5.17 percent. This is a 320 percent decrease over earnings of $0.05 per…- benzinga.com DocGo Narrows FY2025 Sales Guidance from $300.000M-$330.000M to $315.000M-$320.000M vs $317.559M Est DocGo (NASDAQ:DCGO) narrows FY2025 sales outlook from $300.000 million-$330.000 million to $315.000 million-$320.000 million vs $317.559 million estimate.
benzinga.com Earnings Scheduled For November 10, 2025 - benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session